Quarterly Balance Sheet

DAIKEN MEDICAL CO.,LTD - Filing #7716035

Concept As at
2018-12-31
As at
2018-03-31
Quarterly balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,702,867,000 JPY
2,368,211,000 JPY
Work in process
105,905,000 JPY
77,225,000 JPY
Other
124,994,000 JPY
49,566,000 JPY
Allowance for doubtful accounts
-184,000 JPY
-184,000 JPY
Current assets
6,174,173,000 JPY
6,397,581,000 JPY
Non-current assets
Property, plant and equipment
4,303,096,000 JPY
4,394,085,000 JPY
Property, plant and equipment
Buildings
Buildings, net
2,200,533,000 JPY
2,236,975,000 JPY
Land
1,703,670,000 JPY
1,703,670,000 JPY
Other
Other, net
398,892,000 JPY
453,439,000 JPY
Intangible assets
35,589,000 JPY
45,961,000 JPY
Intangible assets
Investments and other assets
294,342,000 JPY
299,522,000 JPY
Investments and other assets
Other
132,279,000 JPY
137,460,000 JPY
Allowance for doubtful accounts
-29,050,000 JPY
-29,050,000 JPY
Non-current assets
4,633,027,000 JPY
4,739,569,000 JPY
Assets
10,807,201,000 JPY
11,137,150,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
990,447,000 JPY
963,255,000 JPY
Short-term borrowings
1,100,000,000 JPY
500,000,000 JPY
Income taxes payable
117,522,000 JPY
181,886,000 JPY
Other
279,221,000 JPY
405,907,000 JPY
Current liabilities
3,667,064,000 JPY
3,051,444,000 JPY
Non-current liabilities
Long-term borrowings
1,357,274,000 JPY
1,361,838,000 JPY
Other
39,136,000 JPY
28,893,000 JPY
Non-current liabilities
1,396,410,000 JPY
1,390,731,000 JPY
Liabilities
5,063,474,000 JPY
4,442,175,000 JPY
Net assets
Shareholders' equity
Share capital
495,875,000 JPY
495,875,000 JPY
Capital surplus
400,875,000 JPY
400,875,000 JPY
Retained earnings
6,619,746,000 JPY
6,619,653,000 JPY
Treasury shares
-1,777,929,000 JPY
-826,588,000 JPY
Shareholders' equity
5,738,566,000 JPY
6,689,814,000 JPY
Share acquisition rights
5,160,000 JPY
5,160,000 JPY
Net assets
5,743,726,000 JPY
6,694,974,000 JPY
Liabilities and net assets
10,807,201,000 JPY
11,137,150,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.